XOMA Royalty (XOMA) Cash from Investing Activities (QoQ) (2010 - 2026)
XOMA Royalty (XOMA) Cash from Investing Activities (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -66.13% |
| Jun 30, 2025 | -198.54% |
| Mar 31, 2025 | 81.63% |
| Dec 31, 2024 | -482.60% |
| Sep 30, 2024 | 61.50% |
| Jun 30, 2024 | 181.37% |
| Mar 31, 2024 | -231.48% |
| Dec 31, 2023 | 0.31% |
| Sep 30, 2023 | 222.58% |
| Jun 30, 2023 | 38.04% |
| Mar 31, 2023 | 52.55% |
| Dec 31, 2022 | -58,742.31% |
| Mar 31, 2022 | 16.67% |
| Dec 31, 2021 | 14.29% |
| Mar 31, 2021 | -6,650.00% |
| Sep 30, 2019 | -116.67% |
| Jun 30, 2019 | -1,900.00% |
| Dec 31, 2017 | 166.67% |
| Sep 30, 2017 | -103.00% |
| Jun 30, 2017 | -1.48% |